More
    Guided Solutions - Connecting Talent With Innovation/div>

    Texas A&M Health, Wave Neuroscience Announce Second Phase of PTSD Clinical Trial

    Efficacy and safety of innovative Magnetic EEG-guided Resonance Therapy (MeRT) will be evaluated Texas A&M University Health Science Center (Texas A&M Health) and Wave Neuroscience...

    LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

    LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 -...

    Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human

    On November , 2021, Aopeng Medical's ALLVAS™ Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted peripheral artery intervention of iliac artery...

    Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA

    The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS Stent Graft System in...

    AHA 2021: Fitbit shows promise for detection of AF

    Results of the Fitbit Heart study, presented during a late-breaking science session at the American Heart Association’s Scientific Sessions 2021 (AHA 2021; 13–15 November;...

    Clinical Studies Demonstrate Patient Benefits of vNOTES Technique

    vNOTES Approach Shown to Shorten Hospital Stay, Lower Pain Scores and Increase Patient Satisfaction Clinical studies demonstrate the considerable patient benefits of the vaginal natural...

    Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes

    The final results of the PROTECT III and Restore EF prospective studies demonstrate improved outcomes for high-risk PCI patients with the use of Impella heart...

    FDA grants breakthrough designation to Magnus’ neurostimulation technology

    In a randomised trial, the neurostimulation technology relieved severe depression in 79% of people. The US Food and Drug Administration (FDA) has granted Breakthrough Device...

    Study finds single-use bronchoscopes reduce hospital readmission rates by half

    A study of 14,228 bronchoscopy procedures found sterile, disposable scopes reduced readmission rates by more than half. The study, authored by Ambu consultant Dr. Hudson Garrett, analyzed...

    Latest articles